Skip to main content
. 2019 Jan 18;2(1):e187147. doi: 10.1001/jamanetworkopen.2018.7147

Table 1. Characteristics of the Study Population.

Variable No. (%)
Age, median (IQR), y 59 (50-69)
Year of breast cancer diagnosis
July-December 2006 21 841 (5.0)
2007-2009 138 482 (31.5)
2010-2012 139 592 (31.7)
2013-2015 139 789 (31.8)
Affiliation with complementary universal health insurancea 19 376 (7.2)
Comorbidities
Measurable history of smoking 24 923 (5.7)
Alcohol use disorder 7113 (1.6)
Obesity 56 174 (12.8)
Medical contraceptionb
IUD 24 260 (22.7)
Birth control pill (reimbursed by health insurance) 12 153 (11.4)
Birth control implant 1676 (1.6)
Hormone replacement therapyc 47 674 (12.7)
Breast cancer type
Invasive 409 523 (93.1)
In situ 30 181 (6.9)
Breast cancer diagnosisd
Mammography 89 427 (95.5)
Biopsy 87 182 (93.1)
Ultrasonography 87 075 (93.0)
MRI 29 506 (31.5)
PET scan 1332 (1.4)
Breast cancer treatmente
Surgical procedure 365 318 (83.1)
Radiation therapy 334 678 (76.1)
Chemotherapy 186 142 (42.3)
Hormone therapy 291 007 (66.2)
Anti–HER2 41 363 (9.4)
Growth factors (antianemic/hematopoietic) 118 692 (27.0)

Abbreviations: IQR, interquartile range; IUD, intrauterine device; MRI, magnetic resonance imaging; PET, positron emission tomography.

a

Free access to health care for people with an annual income less than 50% of the poverty threshold and younger than 65 years (n = 169 031).

b

For patients younger than 50 years (n = 107 004).

c

For patients aged 45 years or older (n = 374 208).

d

For patients included in 2014-2015 (n = 93 615).

e

For any corresponding reimbursement registered within 1 year of cohort entry.